Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:833-837

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, T.
Right arrow Articles by Ban, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, T.
Right arrow Articles by Ban, T.

(Hypertension. 1996;27:833-837.)
© 1996 American Heart Association, Inc.


Articles

Natriuretic Peptide Receptors in Human Artery and Vein and Rabbit Vein Graft

Tadashi Ikeda1; Hiroshi Itoh1; Yasato Komatsu; Michiya Hanyu; Takaaki Yoshimasa; Katsuhiko Matsuda; Kazuwa Nakao; Toshihiko Ban

From the Department of Medicine and Clinical Science (H.I., Y.K., T.Y., K.N.) and the Department of Cardiovascular Surgery (T.I., M.H., K.M., T.B.), Kyoto (Japan) University Graduate School of Medicine.

Correspondence to Katsuhiko Matsuda, MD, Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-01, Japan.

Abstract Natriuretic peptides elicit their biological effects by elevation of cGMP through activation of two biologically active receptors: natriuretic peptide A receptor, which shows high affinity to atrial and brain natriuretic peptides, and natriuretic peptide B receptor, which is specific to C-type natriuretic peptide. To elucidate the implications of the natriuretic peptide system in arteries and veins, we examined the cGMP production in response to atrial and C-type natriuretic peptides and gene expressions of biologically active natriuretic peptide receptors in human gastroepiploic artery, internal mammary artery, and saphenous vein. Atrial natriuretic peptide augmented cGMP production more potently by one order of magnitude in arteries than in veins. C-type natriuretic peptide stimulated cGMP production weakly and equally in these vessels. Analyzed by reverse transcription–polymerase chain reaction, gene expression of natriuretic peptide A receptor was four times more abundant in arteries than in veins. Gene expression of natriuretic peptide B receptor was approximately the same between these vessels. We also studied the responsiveness to atrial and C-type natriuretic peptide in rabbit jugular vein grafted into carotid artery. In arterialized vein grafts 4 weeks after operation, the effects of atrial and C-type natriuretic peptides on cGMP production did not change from those in jugular veins. In conclusion, atrial natriuretic peptide stimulates cGMP production more potently in arteries than in veins due to the preferential expression of natriuretic peptide A receptor in arteries. These observations support the distinct roles of natriuretic peptides in cardiovascular homeostasis.


Key Words: natriuretic peptide • natriuretic peptide receptor • vein graft • cyclic GMP




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Schachner, Y. Zou, A. Oberhuber, T. Mairinger, A. Tzankov, G. Laufer, H. Ott, and J. Bonatti
Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 585 - 590.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Bonatti, W. Dichtl, A. Lercher, and B. Puschendorf
Natriuretic peptides stimulate cyclic guanosine monophosphate production in human saphenous vein and internal mammary artery
Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Bonatti, W. Dichtl, E. A. Dworzak, H. Antretter, F. Unger, B. Puschendorf, and O. E. Dapunt
Atrial Natriuretic Peptide-Induced Release of Cyclic Guanosine Monophosphate by Coronary Bypass Grafts
Ann. Thorac. Surg., June 1, 1998; 65(6): 1621 - 1624.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Lopez, D. L. Garbers, and M. Kuhn
The Guanylyl Cyclase-deficient Mouse Defines Differential Pathways of Natriuretic Peptide Signaling
J. Biol. Chem., September 12, 1997; 272(37): 23064 - 23068.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Ohno, H. Itoh, T. Ikeda, K. Ueyama, K. Yamahara, K. Doi, J. Yamashita, M. Inoue, K. Masatsugu, N. Sawada, et al.
Accelerated Reendothelialization With Suppressed Thrombogenic Property and Neointimal Hyperplasia of Rabbit Jugular Vein Grafts by Adenovirus-Mediated Gene Transfer of C-Type Natriuretic Peptide
Circulation, April 9, 2002; 105(14): 1623 - 1626.
[Abstract] [Full Text] [PDF]